Generalized Anxiety Disorder clinical trials
52 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Text Message Safety Behavior Fading for Pathological Worry
- Brief Smartphone Treatment Study
- Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Massage for GAD: Neuroimaging and Clinical Correlates of Response
- Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
- Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
- Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
- Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
- ACT for Individuals With MNCD and Their Care Partners
- CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
- Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
- Mindful Self-Compassion for Anxiety Disorders and Depression
- Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety
- Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
- Targeting Social Function in Anxiety and Eating Disorders
- Stepped Care Treatment for Anxiety Resilience
- Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Triage Survey for Psychiatry Research Eligibility
- Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
- An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
- Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
- Stress and Anxiety Effects on Valuation
- Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
- Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
- Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
- Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
- Enhancing Health in Rural Populations: Music as Therapy
- Community Care Intervention to Decrease COVID-19 Vaccination Inequities
- The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms
- Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety
- Connectomic Targeted TMS Target for Refractory Anxiety
- LIFU for Chronic Pain and Generalized Anxiety Disorder
- Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials
- Whole-Body Hyperthermia for Mood and Anxiety Disorders
- Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry
- Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
- Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
- Behavioral Telehealth in Low-resource Primary Care Settings for Anxiety and Depression in Youth
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
- Use of CBD in the Treatment of Anxiety
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
- Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Generalized Anxiety Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.